93117-08-9,MFCD06198896
Catalog No.:AA0065N3

93117-08-9 | 5-Aminoisoquinolin-1-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$35.00   $25.00
- +
250mg
98%
in stock  
$72.00   $50.00
- +
1g
98%
in stock  
$202.00   $142.00
- +
5g
98%
in stock  
$583.00   $408.00
- +
10g
98%
in stock  
$964.00   $675.00
- +
25g
98%
in stock  
$1,918.00 $1,343.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0065N3
Chemical Name:
5-Aminoisoquinolin-1-ol
CAS Number:
93117-08-9
Molecular Formula:
C9H8N2O
Molecular Weight:
160.1726
MDL Number:
MFCD06198896
SMILES:
Nc1cccc2c1cc[nH]c2=O
Properties
Properties
 
Form:
Solid  
MP:
249-250°C  
Storage:
Light sensitive;Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
225  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.7  

Literature

Title: 5-AIQ inhibits H2O2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3β signaling pathway in H9c2 cardiomyocytes.

Journal: Toxicology and applied pharmacology 20130401

Title: Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D.

Journal: Journal of neurochemistry 20120701

Title: 5-Aminoisoquinolinone reduces the expression of vascular endothelial growth factor-C via the nuclear factor-κB signaling pathway in CT26 cells.

Journal: Asian Pacific journal of cancer prevention : APJCP 20120101

Title: Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride.

Journal: Journal of enzyme inhibition and medicinal chemistry 20111201

Title: 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).

Journal: Journal of medicinal chemistry 20110414

Title: Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor.

Journal: Organic & biomolecular chemistry 20110207

Title: Parvovirus B19 nonstructural protein-induced damage of cellular DNA and resultant apoptosis.

Journal: International journal of medical sciences 20110101

Title: Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2.

Journal: Vascular cell 20110101

Title: Hepatoprotective effects of select water-soluble PARP inhibitors in a carbon tetrachloride model.

Journal: International journal of critical illness and injury science 20110101

Title: Oocyte numbers in the mouse increase after treatment with 5-aminoisoquinolinone: a potent inhibitor of poly(ADP-ribosyl)ation.

Journal: Biology of reproduction 20100501

Title: PolyADP-ribosylation is required for pronuclear fusion during postfertilization in mice.

Journal: PloS one 20100101

Title: Inhibition of matrix metalloproteinase-2 by PARP inhibitors.

Journal: Biochemical and biophysical research communications 20091002

Title: Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells.

Journal: Pathology oncology research : POR 20090901

Title: Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.

Journal: Archives of pharmacal research 20090701

Title: Poly(ADP-ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology 20090501

Title: Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging.

Journal: Aging 20090501

Title: Design, synthesis, and evaluation in vitro of quinoline-8-carboxamides, a new class of poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) inhibitor.

Journal: Journal of medicinal chemistry 20090212

Title: Influence of 5-aminoisoquinolin-1-one (5-AIQ) on neutrophil chemiluminescence in rats with transient and prolonged focal cerebral ischemia and after reperfusion.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20081201

Title: Bench-to-bedside review: latest results in hemorrhagic shock.

Journal: Critical care (London, England) 20080101

Title: [Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT-29].

Journal: Ai zheng = Aizheng = Chinese journal of cancer 20070601

Title: 5-Aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats.

Journal: Journal of clinical periodontology 20070201

Title: Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.

Journal: PloS one 20070101

Title: Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.

Journal: Biochemical and biophysical research communications 20061201

Title: Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy.

Journal: Methods and findings in experimental and clinical pharmacology 20061201

Title: Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.

Journal: Intensive care medicine 20061001

Title: Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction.

Journal: Mutation research 20050502

Title: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury.

Journal: The Journal of pharmacology and experimental therapeutics 20050501

Title: Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20050301

Title: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.

Journal: The Journal of pharmacology and experimental therapeutics 20050201

Title: Inhibition of poly(ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized Guinea pigs.

Journal: The Journal of pharmacology and experimental therapeutics 20041201

Title: 5-Aminoisoquinolinone reduces colon injury by experimental colitis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20041201

Title: Effects of inhibition of poly(adenosine diphosphate-ribose) synthase on acute cardiac allograft rejection.

Journal: Transplantation 20040915

Title: Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.

Journal: European journal of pharmacology 20040525

Title: 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion.

Journal: Kidney international 20040201

Title: 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion.

Journal: Critical care medicine 20040201

Title: Hepatic microcirculation in ischemia/reperfusion: is there a role for poly(adenosine 5'-diphosphate-ribose) polymerases?

Journal: Critical care medicine 20040201

Title: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat.

Journal: Medical science monitor : international medical journal of experimental and clinical research 20021101

Title: Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury.

Journal: Biochemical pharmacology 20020115

Title: 5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size.

Journal: European journal of pharmacology 20011026

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:93117-08-9 Molecular Formula|93117-08-9 MDL|93117-08-9 SMILES|93117-08-9 5-Aminoisoquinolin-1-ol
Catalog No.: AA0065N3
93117-08-9,MFCD06198896
93117-08-9 | 5-Aminoisoquinolin-1-ol
Pack Size: 100mg
Purity: 97%
in stock
$35.00 $25.00
Pack Size: 250mg
Purity: 98%
in stock
$72.00 $50.00
Pack Size: 1g
Purity: 98%
in stock
$202.00 $142.00
Pack Size: 5g
Purity: 98%
in stock
$583.00 $408.00
Pack Size: 10g
Purity: 98%
in stock
$964.00 $675.00
Pack Size: 25g
Purity: 98%
in stock
$1,918.00 $1,343.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0065N3
Chemical Name: 5-Aminoisoquinolin-1-ol
CAS Number: 93117-08-9
Molecular Formula: C9H8N2O
Molecular Weight: 160.1726
MDL Number: MFCD06198896
SMILES: Nc1cccc2c1cc[nH]c2=O
Properties
Form: Solid  
MP: 249-250°C  
Storage: Light sensitive;Inert atmosphere;2-8℃;  
Complexity: 225  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 12  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.7  
Literature fold

Title: 5-AIQ inhibits H2O2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3β signaling pathway in H9c2 cardiomyocytes.

Journal: Toxicology and applied pharmacology20130401

Title: Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D.

Journal: Journal of neurochemistry20120701

Title: 5-Aminoisoquinolinone reduces the expression of vascular endothelial growth factor-C via the nuclear factor-κB signaling pathway in CT26 cells.

Journal: Asian Pacific journal of cancer prevention : APJCP20120101

Title: Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride.

Journal: Journal of enzyme inhibition and medicinal chemistry20111201

Title: 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).

Journal: Journal of medicinal chemistry20110414

Title: Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor.

Journal: Organic & biomolecular chemistry20110207

Title: Parvovirus B19 nonstructural protein-induced damage of cellular DNA and resultant apoptosis.

Journal: International journal of medical sciences20110101

Title: Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2.

Journal: Vascular cell20110101

Title: Hepatoprotective effects of select water-soluble PARP inhibitors in a carbon tetrachloride model.

Journal: International journal of critical illness and injury science20110101

Title: Oocyte numbers in the mouse increase after treatment with 5-aminoisoquinolinone: a potent inhibitor of poly(ADP-ribosyl)ation.

Journal: Biology of reproduction20100501

Title: PolyADP-ribosylation is required for pronuclear fusion during postfertilization in mice.

Journal: PloS one20100101

Title: Inhibition of matrix metalloproteinase-2 by PARP inhibitors.

Journal: Biochemical and biophysical research communications20091002

Title: Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells.

Journal: Pathology oncology research : POR20090901

Title: Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.

Journal: Archives of pharmacal research20090701

Title: Poly(ADP-ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology20090501

Title: Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging.

Journal: Aging20090501

Title: Design, synthesis, and evaluation in vitro of quinoline-8-carboxamides, a new class of poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) inhibitor.

Journal: Journal of medicinal chemistry20090212

Title: Influence of 5-aminoisoquinolin-1-one (5-AIQ) on neutrophil chemiluminescence in rats with transient and prolonged focal cerebral ischemia and after reperfusion.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society20081201

Title: Bench-to-bedside review: latest results in hemorrhagic shock.

Journal: Critical care (London, England)20080101

Title: [Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT-29].

Journal: Ai zheng = Aizheng = Chinese journal of cancer20070601

Title: 5-Aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats.

Journal: Journal of clinical periodontology20070201

Title: Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.

Journal: PloS one20070101

Title: Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.

Journal: Biochemical and biophysical research communications20061201

Title: Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy.

Journal: Methods and findings in experimental and clinical pharmacology20061201

Title: Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.

Journal: Intensive care medicine20061001

Title: Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction.

Journal: Mutation research20050502

Title: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury.

Journal: The Journal of pharmacology and experimental therapeutics20050501

Title: Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.

Journal: Toxicological sciences : an official journal of the Society of Toxicology20050301

Title: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.

Journal: The Journal of pharmacology and experimental therapeutics20050201

Title: Inhibition of poly(ADP-ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized Guinea pigs.

Journal: The Journal of pharmacology and experimental therapeutics20041201

Title: 5-Aminoisoquinolinone reduces colon injury by experimental colitis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology20041201

Title: Effects of inhibition of poly(adenosine diphosphate-ribose) synthase on acute cardiac allograft rejection.

Journal: Transplantation20040915

Title: Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.

Journal: European journal of pharmacology20040525

Title: 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion.

Journal: Kidney international20040201

Title: 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion.

Journal: Critical care medicine20040201

Title: Hepatic microcirculation in ischemia/reperfusion: is there a role for poly(adenosine 5'-diphosphate-ribose) polymerases?

Journal: Critical care medicine20040201

Title: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat.

Journal: Medical science monitor : international medical journal of experimental and clinical research20021101

Title: Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury.

Journal: Biochemical pharmacology20020115

Title: 5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size.

Journal: European journal of pharmacology20011026

Building Blocks More >
99009-85-5
99009-85-5
4-Isobutylamino-3-nitroquinoline
AA0066G1 | MFCD07787597
98591-49-2
98591-49-2
1H-Indole-2-carboxylicacid, 3,5-dibromo-
AA0067B2 | MFCD09027182
71422-67-8
71422-67-8
Chlorfluazuron
AA00686N | MFCD00143948
893738-44-8
893738-44-8
2-Amino-5-(4-methylthiophenyl)pyridine
AA00691Q | MFCD06802148
945896-38-8
945896-38-8
4-tert-Butylamino-6-chloropyrimidine
AA0069VE | MFCD09756959
97909-55-2
97909-55-2
Methyl 4-aminoquinoline-2-carboxylate
AA006AJE | MFCD18910405
711-33-1
711-33-1
4'-(Trifluoromethyl)propiophenone
AA006BG3 | MFCD00039231
70110-38-2
70110-38-2
2-Bromo-n-(1-phenylethyl)acetamide
AA006C74 | MFCD05624926
68223-64-3
68223-64-3
4-Fluorocyclohexanone
AA006D0B | MFCD11520472
927802-20-8
927802-20-8
1-Ethyl-1H-indazol-3-amine
AA006DY0 | MFCD09054756
Submit
© 2017 AA BLOCKS, INC. All rights reserved.